Search

Your search keyword '"Corrada, E."' showing total 101 results

Search Constraints

Start Over You searched for: Author "Corrada, E." Remove constraint Author: "Corrada, E."
101 results on '"Corrada, E."'

Search Results

2. Corrigendum to “Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial” [Int J Cardiol. 2022 Dec 15;369:5-11]

3. 24h SCAI stage reclassification to predict outcome. Insights from the prospective Altshock-2 registry

5. A prospective registry to get insights into profile, management and outcome of cardiogenic shock patients

6. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

8. Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

9. G-CSF for Extensive STEMI: Results from the STEM-AMI OUTCOME CMR Substudy

10. G-CSF for Extensive STEMI

11. How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study

12. Healthcare professionals’ knowledge on cardiopulmonary resuscitation correlated with return of spontaneous circulation rates after in-hospital cardiac arrests: A multicentric study between university hospitals in 12 European countries

13. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

15. Vasopressors and inotropes in cardiogenic shock: Is there room for 'adrenaline resuscitation'?

16. Vorapaxar in the secondary prevention of atherothrombotic events

17. Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

18. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

23. Exercise testing and dipyridamole echocardiography test before and 48 h after successful coronary angioplasty: prognostic implications.

24. Dipyridamole–thallium 201 scintigraphy in the early post-infarction period: (Safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first mycocardial infarction).

25. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.

31. Admission glycemia and markers of inflammation are independent outcome predictors in primary PCI in non-diabetic patients

33. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

35. G-CSF for Extensive STEMI

36. Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

37. Vasopressors and inotropes in cardiogenic shock: is there room for 'adrenaline resuscitation'?

38. GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis.

39. Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction.

40. SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock-2 registry.

41. Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.

42. Association of Sex with Outcome in Elderly Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

43. Clinical Challenges in an Unusual Setting: ST-Elevation in a Patient Suffering From Graft Versus Host Disease, Between Thrombosis and Coronary Spasm.

44. Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: Rationale and design of the randomized Altshock-2 trial.

45. [Percutaneous mitral valve repair in acute mitral regurgitation].

46. Timing of Oral P2Y 12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

47. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19.

48. Impact of diabetes on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: insights from the ELDERLY ACS 2 trial.

49. Healthcare professionals' knowledge on cardiopulmonary resuscitation correlated with return of spontaneous circulation rates after in-hospital cardiac arrests: A multicentric study between university hospitals in 12 European countries.

50. Impact of body mass index on clinical outcome among elderly patients with acute coronary syndrome treated with percutaneous coronary intervention: Insights from the ELDERLY ACS 2 trial.

Catalog

Books, media, physical & digital resources